A phase 1/2, open-label study to evaluate the safety, tolerability, pharmacokinetics and efficacy of D-1553 in subjects with advanced or metastatic solid tumors with KRasG12C mutation

  • Richardson, Gary (Primary Chief Investigator (PCI))
  • Lai, Li Hoon (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date20/01/2131/12/23

Keywords

  • Medical oncology
  • Solid tumours
  • Clinical trial